Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Le Bouc, Raphaela; 1 | Marelli, Ceciliab; 1 | Beaufils, Emiliec; 1 | Berr, Claudined | Hommet, Carolinec | Touchon, Jacquesb | Pasquier, Florencea | Deramecourt, Vincenta; *
Affiliations: [a] Memory Clinic, French National Reference Centre for Young Onset Alzheimer’s disease, Lille University Hospital, INSERM U1171, LabEx DISTALZ, Lille, France | [b] Department of Neurology, CHRU Gui de Chauliac, Montpellier, France | [c] Regional Memory Center, CHU Hôpital Bretonneau, Tours, France | [d] INSERM E361, Pathologies of the Nervous System, Clinical and Epidemiological Research, Hôpital La Colombiére, Montpellier, France
Correspondence: [*] Correspondence to: Vincent Deramecourt, MD, PhD, MemoryClinic, University Hospital, F-59037 Lille, France. Tel.: +33 0 320446021; Fax: +33 0 320445493; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Postmortem neuropathological examination of the brain is essential in neurodegenerative diseases, to ensure accurate diagnosis, to obtain an a posteriori critical assessment of the adequacy of clinical care, and to validate new biomarkers, but is only rarely performed. The purpose of this study was to assess factors limiting brain donation, such as reluctance of physicians to seek donation consent, opposition from patients and families, and organizational constraints. We conducted a survey across French memory clinics and major neuropathological centers. Few postmortem examinations were performed annually, as less than one third of the centers had performed at least five autopsies, and 41% had performed none. The main limiting factor was the lack of donation requests made by physicians, as half of them never approach patients for brain donation. Reasons for not seeking donation consent often include discomfort broaching the subject and lack of awareness of the medical and scientific benefit of postmortems (77%), organizational constraints (61%), and overestimation of families’ negative reaction (51%). Family refusals represented a second major obstacle, and were often caused by misconceptions. Identifying and addressing these biases early could help improve physicians’ rate of making requests and the public’s awareness about the importance of brain donation.
Keywords: Alzheimer’s disease, brain bank, brain donation, neurodegenerative diseases, postmortem examination
DOI: 10.3233/JAD-150825
Journal: Journal of Alzheimer's Disease, vol. 49, no. 4, pp. 1075-1083, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]